EUVIMEDEUVIMED entdecken
Kohortenstudie

Tacrolimus in Pediatric Solid Organ Transplant Recipients: A Retrospective Cohort Study

Dhrita Khatri iD, Julia Netylko iD, David Metz iD, Yongqi Sun, Joshua Kausman iD, Jacob Mathew iD, Elizabeth Bannister iD, Amanda Gwee iD, John Christodoulou iD, Tayla Stenta iD, Claire Moore iD, Elizabeth Williams iD und 4 weitere

Pediatric Transplantation · 2026

DOI: 10.1111/petr.70370 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Pediatric Transplantation, 2026. Verfasst von Dhrita Khatri und 15 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Therapies Group, Murdoch Children's Research Institute, Parkville, Australia. Hauptthemen laut MEDLINE: Tacrolimus, Immunosuppressive Agents, Graft Rejection, Organ Transplantation. Die Arbeit nennt 41 Literaturangaben. Gefördert von: 2023 Medical Research Future Fund - Genomics Health Future Mission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tacrolimus is an effective immunosuppressant used after transplantation to prevent organ rejection. Standard tacrolimus dosing relies on therapeutic drug monitoring and does not account for patient‐specific factors, contributing to substantial inter‐individual variability. In this retrospective study, tacrolimus target attainment and intra‐patient variability under standard care were investigated in pediatric solid organ transplant recipients.

Methods

In a cohort of 39 kidney, 31 liver, 48 heart, and 1 liver‐kidney transplant recipients, tacrolimus trough concentrations from days 4 to 56 post‐initiation of tacrolimus were analyzed. T ime in target range (TTR) and intra‐patient variability (coefficient of variation) were calculated over the 8‐week period. Secondary outcome analyses examined associations between TTR and clinical outcomes.

Results

Across all groups, target attainment was lowest on day 4 and improved by days 21 and 56, but remained suboptimal, particularly among liver recipients (day 56: Heart 45%, kidney 76%, liver 31%). Average TTR was highest in the kidney (60%) and lowest in the liver recipients (27%), with only 3% of liver recipients spending at least half of the time within the target.

Conclusions

Standard tacrolimus dosing often results in out‐of‐target exposure, with particularly poor target attainment and high variability among pediatric liver transplant recipients. These findings highlight the limitations of current approaches and support the need for more individualized strategies, including genotype‐guided dosing, to improve target attainment and outcomes in pediatric transplant recipients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TacrolimusImmunosuppressive AgentsGraft RejectionOrgan TransplantationHumansRetrospective StudiesChildFemaleChild, PreschoolMaleDrug MonitoringAdolescentInfantLiver TransplantationTreatment OutcomeKidney TransplantationHeart Transplantation

Stichwörter der Autor:innen

immunosuppressionorgan rejectionpharmacokineticspharmacologytherapeutic drug monitoring

Substanzen

TacrolimusImmunosuppressive Agents

Autor:innen und Institutionen

  • Cancer Therapies Group, Murdoch Children's Research Institute, Parkville, Australia.
  • Department of Paediatrics, The University of Melbourne, Parkville, Australia.
  • Department of Nephrology, The Royal Children's Hospital, Melbourne, Australia.
  • Department of Paediatrics, Monash University, Melbourne, Victoria, Australia.
  • Murdoch Children's Research Institute, Parkville, Australia.
  • Faculty of Pharmaceutical Science, Monash University, Parkville, Australia.

ORCID-Profile: Dhrita Khatri, Julia Netylko, David Metz, Joshua Kausman, Jacob Mathew, Elizabeth Bannister, Amanda Gwee, John Christodoulou, Tayla Stenta, Claire Moore, Elizabeth Williams, Roxanne Dyas, Julian Stolper, Andreas Halman, Rachel Conyers

Förderung

  • 2023 Medical Research Future Fund - Genomics Health Future Mission

Zitieren

APA

Khatri, D., Netylko, J., Metz, D., Sun, Y., Kausman, J., Mathew, J., Bannister, E., Gwee, A., Christodoulou, J., Stenta, T., Moore, C., Williams, E., Dyas, R., Stolper, J., Halman, A., & Conyers, R. (2026). Tacrolimus in Pediatric Solid Organ Transplant Recipients: A Retrospective Cohort Study. Pediatric Transplantation. https://doi.org/10.1111/petr.70370

Vancouver

Khatri D, Netylko J, Metz D, Sun Y, Kausman J, Mathew J, et al. Tacrolimus in Pediatric Solid Organ Transplant Recipients: A Retrospective Cohort Study. Pediatric Transplantation. 2026. doi:10.1111/petr.70370

BibTeX
@article{Khatri2026,
  author = {Khatri, Dhrita and Netylko, Julia and Metz, David and Sun, Yongqi and Kausman, Joshua and Mathew, Jacob and Bannister, Elizabeth and Gwee, Amanda and Christodoulou, John and Stenta, Tayla and Moore, Claire and Williams, Elizabeth and Dyas, Roxanne and Stolper, Julian and Halman, Andreas and Conyers, Rachel},
  title = {Tacrolimus in Pediatric Solid Organ Transplant Recipients: A Retrospective Cohort Study},
  journal = {Pediatric Transplantation},
  year = {2026},
  doi = {10.1111/petr.70370}
}
Kostenlos starten →